Covered recipient · General Payments record
IVETTE CARDONA RUELLE
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2019–2025
$4,153.34
- Reported across 131 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $806.22 | 16 |
| Long term medical supply or device loan | $274.95 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $578.85 | 5 |
| Amgen Inc. | $293.31 | 7 |
| Acerta Pharma LLC | $124.95 | 1 |
| AngioDynamics, Inc. | $27.95 | 1 |
| Lilly USA, LLC | $21.75 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.92 | 1 |
| Exact Sciences Corporation | $16.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $274.95 | 04/14/2025 | Long term medical supply or device loan | Undisputed | 06/30/2026 | 1240590379 | CMS |
| Abbott Laboratories | $131.78 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240997348 | CMS |
| Abbott Laboratories | $23.17 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240892330 | CMS |
| Abbott Laboratories | $125.00 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241008535 | CMS |
| Abbott Laboratories | $23.95 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240892846 | CMS |
| Amgen Inc. | $11.75 | 01/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227120997 | CMS |
| Amgen Inc. | $123.97 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228349688 | CMS |
| Amgen Inc. | $7.67 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227120995 | CMS |
| Amgen Inc. | $13.90 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227120999 | CMS |
| Amgen Inc. | $7.24 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227120993 | CMS |
| Amgen Inc. | $6.51 | 08/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227120991 | CMS |
| Amgen Inc. | $122.27 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228349686 | CMS |
| AngioDynamics, Inc. | $27.95 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220847651 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.95 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206832359 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.92 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225486492 | CMS |
| Exact Sciences Corporation | $16.44 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235702377 | CMS |
| Lilly USA, LLC | $21.75 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186655195 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.